NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|24647274|ref|NP_650507|]
View 

uncharacterized protein Dmel_CG14877 [Drosophila melanogaster]

Protein Classification

type 1 periplasmic-binding domain-containing protein( domain architecture ID 70)

type 1 periplasmic-binding domain-containing protein such as the ligand binding domains of the LacI family of transcriptional regulators, the ABC transporter substrate-binding proteins, the family C GPCRs, membrane bound guanylyl cyclases including the family of natriuretic peptide receptors (NPRs), and the N-terminal LIVBP-like domains of the ionotropic glutamate receptors (iGluRs); contains the Venus flytrap-like domain which undergoes transition from an open to a closed conformational state upon ligand binding

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Periplasmic_Binding_Protein_type1 super family cl10011
Type 1 periplasmic binding fold superfamily; Type 1 periplasmic binding fold superfamily. This ...
45-251 3.43e-35

Type 1 periplasmic binding fold superfamily; Type 1 periplasmic binding fold superfamily. This model and hierarchy represent the ligand binding domains of the LacI family of transcriptional regulators, periplasmic binding proteins of the ABC-type transport systems, the family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases including the family of natriuretic peptide receptors (NPRs), and the N-terminal leucine-isoleucine-valine binding protein (LIVBP)-like domains of the ionotropic glutamate receptors (iGluRs). In LacI-like transcriptional regulator and the bacterial periplasmic binding proteins, the ligands are monosaccharides, including lactose, ribose, fructose, xylose, arabinose, galactose/glucose and other sugars, with a few exceptions. Periplasmic sugar binding proteins are one of the components of ABC transporters and are involved in the active transport of water-soluble ligands. The LacI family of proteins consists of transcriptional regulators related to the lac repressor. In this case, the sugar binding domain binds a sugar which changes the DNA binding activity of the repressor domain. The periplasmic binding proteins are the primary receptors for chemotaxis and transport of many sugar based solutes. The core structures of periplasmic binding proteins are classified into two types, and they differ in number and order of beta strands: type 1 has six beta strands while type 2 has five beta strands per sub-domain. These two structural folds are thought to be distantly related via a common ancestor. Notably, while the N-terminal LIVBP-like domain of iGluRs belongs to the type 1 periplasmic-binding fold protein superfamily, the glutamate-binding domain of the iGluR is structurally similar to the type 2 periplasmic-binding fold.


The actual alignment was detected with superfamily member cd06373:

Pssm-ID: 471960 [Multi-domain]  Cd Length: 394  Bit Score: 129.32  E-value: 3.43e-35
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274  45 LVLLPDDNMYQASLPRVLPILKVAEQQIRSKSLIPsHIDFEWLAHDTKCDASLGVIKAMDGIIKQCAQVIFGPVCDYSLA 124
Cdd:cd06373   3 AVLLPQDDSYPFSLAKVLPAIELALRRVERRGFLP-GWRFQVHYRDTKCSDTLAPLAAVDLYCAKKVDVFLGPVCEYALA 81
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274 125 AVSRITKYFNsqgTPLISVGGSTYDFEQKktdcnDEFYMLLRTGMlSFETISELTINVMKRHNWSHSIFYYERDGQRSvA 204
Cdd:cd06373  82 PVARYAGHWN---VPVLTAGGLAAGFDDK-----TEYPLLTRMGG-SYVKLGEFVLTLLRHFGWRRVALLYHDNLRRK-A 151
                       170       180       190       200
                ....*....|....*....|....*....|....*....|....*...
gi 24647274 205 GMHTCFLMMKSLGKQMRNENMT-FAQFPLEPNLTNRTEEMRREIGNKH 251
Cdd:cd06373 152 GNSNCYFTLEGIFNALTGERDSiHKSFDEFDETKDDFEILLKRVSNSA 199
 
Name Accession Description Interval E-value
PBP1_NPR-like cd06373
Ligand binding domain of natriuretic peptide receptor (NPR) family; Ligand binding domain of ...
45-251 3.43e-35

Ligand binding domain of natriuretic peptide receptor (NPR) family; Ligand binding domain of natriuretic peptide receptor (NPR) family which consists of three different subtypes: type A natriuretic peptide receptor (NPR-A, or GC-A), type B natriuretic peptide receptors (NPR-B, or GC-B), and type C natriuretic peptide receptor (NPR-C). There are three types of natriuretic peptide (NP) ligands specific to the receptors: atrial NP (ANP), brain or B-type NP (BNP), and C-type NP (CNP). The NP family is thought to have arisen through gene duplication during evolution and plays an essential role in cardiovascular and body fluid homeostasis. ANP and BNP bind mainly to NPR-A, while CNP binds specifically to NPR-B. Both NPR-A and NPR-B have guanylyl cyclase catalytic activity and produces intracellular secondary messenger cGMP in response to peptide-ligand binding. Consequently, the NPR-A activation results in vasodilation and inhibition of vascular smooth muscle cell proliferation. NPR-C acts as the receptor for all the three members of NP family, and functions as a clearance receptor. Unlike NPR-A and -B, NPR-C lacks an intracellular guanylyl cyclase domain and is thought to exert biological actions by sequestration of released natriuretic peptides and/or inhibition of adenylyl cyclase.


Pssm-ID: 380596 [Multi-domain]  Cd Length: 394  Bit Score: 129.32  E-value: 3.43e-35
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274  45 LVLLPDDNMYQASLPRVLPILKVAEQQIRSKSLIPsHIDFEWLAHDTKCDASLGVIKAMDGIIKQCAQVIFGPVCDYSLA 124
Cdd:cd06373   3 AVLLPQDDSYPFSLAKVLPAIELALRRVERRGFLP-GWRFQVHYRDTKCSDTLAPLAAVDLYCAKKVDVFLGPVCEYALA 81
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274 125 AVSRITKYFNsqgTPLISVGGSTYDFEQKktdcnDEFYMLLRTGMlSFETISELTINVMKRHNWSHSIFYYERDGQRSvA 204
Cdd:cd06373  82 PVARYAGHWN---VPVLTAGGLAAGFDDK-----TEYPLLTRMGG-SYVKLGEFVLTLLRHFGWRRVALLYHDNLRRK-A 151
                       170       180       190       200
                ....*....|....*....|....*....|....*....|....*...
gi 24647274 205 GMHTCFLMMKSLGKQMRNENMT-FAQFPLEPNLTNRTEEMRREIGNKH 251
Cdd:cd06373 152 GNSNCYFTLEGIFNALTGERDSiHKSFDEFDETKDDFEILLKRVSNSA 199
ANF_receptor pfam01094
Receptor family ligand binding region; This family includes extracellular ligand binding ...
60-198 3.25e-10

Receptor family ligand binding region; This family includes extracellular ligand binding domains of a wide range of receptors. This family also includes the bacterial amino acid binding proteins of known structure.


Pssm-ID: 460062 [Multi-domain]  Cd Length: 347  Bit Score: 59.32  E-value: 3.25e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274    60 RVLPILKVAEQQIRSKSLIPSHIDFEWLAHDTKCDASLGVIKAMDgIIKQCAQVIFGPVCDYSLAAVSRITKYFNsqgTP 139
Cdd:pfam01094   1 LVLLAVRLAVEDINADPGLLPGTKLEYIILDTCCDPSLALAAALD-LLKGEVVAIIGPSCSSVASAVASLANEWK---VP 76
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 24647274   140 LISVGGSTYDFEQKktdcnDEFYMLLRTgMLSFETISELTINVMKRHNWSHSIFYYERD 198
Cdd:pfam01094  77 LISYGSTSPALSDL-----NRYPTFLRT-TPSDTSQADAIVDILKHFGWKRVALIYSDD 129
 
Name Accession Description Interval E-value
PBP1_NPR-like cd06373
Ligand binding domain of natriuretic peptide receptor (NPR) family; Ligand binding domain of ...
45-251 3.43e-35

Ligand binding domain of natriuretic peptide receptor (NPR) family; Ligand binding domain of natriuretic peptide receptor (NPR) family which consists of three different subtypes: type A natriuretic peptide receptor (NPR-A, or GC-A), type B natriuretic peptide receptors (NPR-B, or GC-B), and type C natriuretic peptide receptor (NPR-C). There are three types of natriuretic peptide (NP) ligands specific to the receptors: atrial NP (ANP), brain or B-type NP (BNP), and C-type NP (CNP). The NP family is thought to have arisen through gene duplication during evolution and plays an essential role in cardiovascular and body fluid homeostasis. ANP and BNP bind mainly to NPR-A, while CNP binds specifically to NPR-B. Both NPR-A and NPR-B have guanylyl cyclase catalytic activity and produces intracellular secondary messenger cGMP in response to peptide-ligand binding. Consequently, the NPR-A activation results in vasodilation and inhibition of vascular smooth muscle cell proliferation. NPR-C acts as the receptor for all the three members of NP family, and functions as a clearance receptor. Unlike NPR-A and -B, NPR-C lacks an intracellular guanylyl cyclase domain and is thought to exert biological actions by sequestration of released natriuretic peptides and/or inhibition of adenylyl cyclase.


Pssm-ID: 380596 [Multi-domain]  Cd Length: 394  Bit Score: 129.32  E-value: 3.43e-35
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274  45 LVLLPDDNMYQASLPRVLPILKVAEQQIRSKSLIPsHIDFEWLAHDTKCDASLGVIKAMDGIIKQCAQVIFGPVCDYSLA 124
Cdd:cd06373   3 AVLLPQDDSYPFSLAKVLPAIELALRRVERRGFLP-GWRFQVHYRDTKCSDTLAPLAAVDLYCAKKVDVFLGPVCEYALA 81
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274 125 AVSRITKYFNsqgTPLISVGGSTYDFEQKktdcnDEFYMLLRTGMlSFETISELTINVMKRHNWSHSIFYYERDGQRSvA 204
Cdd:cd06373  82 PVARYAGHWN---VPVLTAGGLAAGFDDK-----TEYPLLTRMGG-SYVKLGEFVLTLLRHFGWRRVALLYHDNLRRK-A 151
                       170       180       190       200
                ....*....|....*....|....*....|....*....|....*...
gi 24647274 205 GMHTCFLMMKSLGKQMRNENMT-FAQFPLEPNLTNRTEEMRREIGNKH 251
Cdd:cd06373 152 GNSNCYFTLEGIFNALTGERDSiHKSFDEFDETKDDFEILLKRVSNSA 199
PBP1_NPR_GC-like cd06352
ligand-binding domain of membrane guanylyl-cyclase receptors; Ligand-binding domain of ...
45-240 3.78e-25

ligand-binding domain of membrane guanylyl-cyclase receptors; Ligand-binding domain of membrane guanylyl-cyclase receptors. Membrane guanylyl cyclases (GC) have a single membrane-spanning region and are activated by endogenous and exogenous peptides. This family can be divided into three major subfamilies: the natriuretic peptide receptors (NPRs), sensory organ-specific membrane GCs, and the enterotoxin/guanylin receptors. The binding of peptide ligands to the receptor results in the activation of the cytosolic catalytic domain. Three types of NPRs have been cloned from mammalian tissues: NPR-A/GC-A, NPR-B/ GC-B, and NPR-C. In addition, two of the GCs, GC-D and GC-G, appear to be pseudogenes in humans. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are produced in the heart, and both bind to the NPR-A. NPR-C, also termed the clearance receptor, binds each of the natriuretic peptides and can alter circulating levels of these peptides. The ligand binding domain of the NPRs exhibits strong structural similarity to the type 1 periplasmic binding fold protein family.


Pssm-ID: 380575 [Multi-domain]  Cd Length: 391  Bit Score: 102.05  E-value: 3.78e-25
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274  45 LVLLPDDNMYQA-SLPRVLPILKVAEQQIRSKSLIPSHIDFEWLAHDTKCDASLGVIKAMDGIIKQCAQVIFGPVCDYSL 123
Cdd:cd06352   3 GVLAPSNSQSLPvGYARSAPAIDIAIERINSEGLLLPGFNFEFTYRDSCCDESEAVGAAADLIYKRNVDVFIGPACSAAA 82
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274 124 AAVSRITKYFNsqgTPLISVGGSTYDFEQKktdcnDEFYMLLRTGMLSFeTISELTINVMKRHNWSHSIFYYERDGQRsv 203
Cdd:cd06352  83 DAVGRLATYWN---IPIITWGAVSASFLDK-----SRYPTLTRTSPNSL-SLAEALLALLKQFNWKRAAIIYSDDDSK-- 151
                       170       180       190
                ....*....|....*....|....*....|....*...
gi 24647274 204 agmhtCFLMMKSLGKQMRNE-NMTFAQFPLEPNLTNRT 240
Cdd:cd06352 152 -----CFSIANDLEDALNQEdNLTISYYEFVEVNSDSD 184
PBP1_NPR_C cd06386
ligand-binding domain of type C natriuretic peptide receptor; Ligand-binding domain of type C ...
41-250 4.23e-18

ligand-binding domain of type C natriuretic peptide receptor; Ligand-binding domain of type C natriuretic peptide receptor (NPR-C). NPR-C is found in atrial, mesentery, placenta, lung, kidney, venous tissue, aortic smooth muscle, and aortic endothelial cells. The affinity of NPR-C for natriuretic peptides is ANP>CNP>BNP. The extracellular domain of NPR-C is about 30% identical to NPR-A and NPR-B. However, unlike the cyclase-linked receptors, it contains only 37 intracellular amino acids and no guanylyl cyclase activity. Major function of NPR-C is to clear natriuretic peptides from the circulation or extracellular surroundings through constitutive receptor-mediated internalization and degradation.


Pssm-ID: 380609 [Multi-domain]  Cd Length: 391  Bit Score: 82.60  E-value: 4.23e-18
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274  41 TIRALVLLPDDNMYQASLPRVLPILKVAEQQIRSKSLIPSHIDFEWLAHDTKC-DASLGVIKAMDGIIKQCAQVIFGPVC 119
Cdd:cd06386   2 KIEVLVLLPKDNSYLFSLTRVRPAIEYALRSVEGNGLLPPGTRFNVAYEDSDCgNRALFSLVDRVAQKRAKPDLILGPVC 81
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274 120 DYSLAAVSRITKYFNsqgTPLISVGGSTYDFEQKKTdcndEFYMLLRTGMlSFETISELTINVMKRHNWSHSIFYYERDG 199
Cdd:cd06386  82 EYAAAPVARLASHWN---LPMLSAGALAAGFSHKDS----EYSHLTRVAP-AYAKMGEMFLALFRHHHWSRAFLVYSDDK 153
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|.
gi 24647274 200 QRsvagmHTCFLMMKSLGKQMRNENMTFAQFPLEPNLTNRTEEMRREIGNK 250
Cdd:cd06386 154 LE-----RNCYFTLEGVHEVFQEEGLHTSIYSFDETKDLDLEEIVRNIQAS 199
PBP1_NPR_B cd06384
ligand-binding domain of type B natriuretic peptide receptor; Ligand-binding domain of type B ...
46-189 2.54e-14

ligand-binding domain of type B natriuretic peptide receptor; Ligand-binding domain of type B natriuretic peptide receptor (NPR-B). NPR-B is one of three known single membrane-spanning natriuretic peptide receptors that have been identified. Natriuretic peptides are family of structurally related but genetically distinct hormones/paracrine factors that regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat metabolism, and long bone growth. In mammals there are three natriuretic peptides: ANP, BNP, and CNP. Like NPR-A (or GC-A), NPR-B (or GC-B) is a transmembrane guanylyl cyclase, an enzyme that catalyzes the synthesis of cGMP. NPR-B is the predominant natriuretic peptide receptor in the brain. The rank of order activation of NPR-B by natriuretic peptides is CNP>>ANP>BNP. Homozygous inactivating mutations in human NPR-B cause a form of short-limbed dwarfism known as acromesomelic dysplasia type Maroteaux.


Pssm-ID: 380607 [Multi-domain]  Cd Length: 399  Bit Score: 71.81  E-value: 2.54e-14
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274  46 VLLPDDNM-YQASLPRVLPILKVAEQQIRSKSLIPSHIDFEWLAHDTK----CDASLGVIKAMDGIIKQCAQVIFGPVCD 120
Cdd:cd06384   4 VVLPENNLsYAWAWPRVFPALRMAVDALQRKGKLLRGYTVNLLFHSSElqgaCSEYVAPLMAVDLKLYHDPDVLFGPGCV 83
                        90       100       110       120       130       140
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 24647274 121 YSLAAVSRITKYFNsqgTPLISVGGSTYDFEQKktdcNDEFYMLLRTGmLSFETISELTINVMKRHNWS 189
Cdd:cd06384  84 YPAASVGRFASHWR---LPLITAGAVAFGFSSK----DEHYRTTVRTG-PSAPKLGEFVSHLHSHFNWT 144
PBP1_NPR_A cd06385
Ligand-binding domain of type A natriuretic peptide receptor; Ligand-binding domain of type A ...
46-250 1.68e-10

Ligand-binding domain of type A natriuretic peptide receptor; Ligand-binding domain of type A natriuretic peptide receptor (NPR-A). NPR-A is one of three known single membrane-spanning natriuretic peptide receptors that regulate blood volume, blood pressure, ventricular hypertrophy, pulmonary hypertension, fat metabolism, and long bone growth. In mammals there are three natriuretic peptides: ANP, BNP, and CNP. NPR-A is highly expressed in kidney, adrenal, terminal ileum, adipose, aortic, and lung tissues. The rank order of NPR-A activation by natriuretic peptides is ANP>BNP>>CNP. Single allele-inactivating mutations in the promoter of human NPR-A are associated with hypertension and heart failure.


Pssm-ID: 380608 [Multi-domain]  Cd Length: 408  Bit Score: 60.60  E-value: 1.68e-10
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274  46 VLLPDDNM-YQASLPRVLPILKVAEQQIRSK-SLIPSHiDFEWLAHDTK-----CDASLGVIKAMDGIIKQCAQVIFGPV 118
Cdd:cd06385   4 VVLPLTNTsYPWAWPRVGPAVELALERVNARpDLLPGW-HVRTVLGSSEnkegvCSDSTAPLVAVDLKFEHHPAVFLGPG 82
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274 119 CDYSLAAVSRITKYFnsqGTPLISVGGSTYDFEQKktdcnDEFYMLLRTGmLSFETISELTINVMKRHNWSHS---IFYY 195
Cdd:cd06385  83 CVYTAAPVARFTAHW---RVPLLTAGAPALGFGVK-----DEYALTTRTG-PSHKKLGEFVARLHRRYGWERRallVYAD 153
                       170       180       190       200       210
                ....*....|....*....|....*....|....*....|....*....|....*.
gi 24647274 196 ERDGQRSvagmhtCFLMMKSLGKQMRNE-NMTFAQFPLEPNLTNRTEEMRREIGNK 250
Cdd:cd06385 154 RKGDDRP------CFFAVEGLYMQLRRRlNITVDDLVFNEDEPLNYTELLRDIRQK 203
ANF_receptor pfam01094
Receptor family ligand binding region; This family includes extracellular ligand binding ...
60-198 3.25e-10

Receptor family ligand binding region; This family includes extracellular ligand binding domains of a wide range of receptors. This family also includes the bacterial amino acid binding proteins of known structure.


Pssm-ID: 460062 [Multi-domain]  Cd Length: 347  Bit Score: 59.32  E-value: 3.25e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274    60 RVLPILKVAEQQIRSKSLIPSHIDFEWLAHDTKCDASLGVIKAMDgIIKQCAQVIFGPVCDYSLAAVSRITKYFNsqgTP 139
Cdd:pfam01094   1 LVLLAVRLAVEDINADPGLLPGTKLEYIILDTCCDPSLALAAALD-LLKGEVVAIIGPSCSSVASAVASLANEWK---VP 76
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 24647274   140 LISVGGSTYDFEQKktdcnDEFYMLLRTgMLSFETISELTINVMKRHNWSHSIFYYERD 198
Cdd:pfam01094  77 LISYGSTSPALSDL-----NRYPTFLRT-TPSDTSQADAIVDILKHFGWKRVALIYSDD 129
PBP1_glutamate_receptors-like cd06269
ligand-binding domain of family C G-protein couples receptors (GPCRs), membrane bound guanylyl ...
46-210 3.60e-08

ligand-binding domain of family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases such as natriuretic peptide receptors (NPRs), and N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of ionotropic glutamate rece; This CD represents the ligand-binding domain of the family C G-protein couples receptors (GPCRs), membrane bound guanylyl cyclases such as the family of natriuretic peptide receptors (NPRs), and the N-terminal leucine-isoleucine-valine binding protein (LIVBP)-like domain of the ionotropic glutamate receptors, all of which are structurally similar and related to the periplasmic-binding fold type 1 family. The family C GPCRs consists of metabotropic glutamate receptor (mGluR), a calcium-sensing receptor (CaSR), gamma-aminobutyric acid receptor (GABAbR), the promiscuous L-alpha-amino acid receptor GPR6A, families of taste and pheromone receptors, and orphan receptors. Truncated splicing variants of the orphan receptors are not included in this CD. The family C GPCRs are activated by endogenous agonists such as amino acids, ions, and sugar based molecules. Their amino terminal ligand-binding region is homologous to the bacterial leucine-isoleucine-valine binding protein (LIVBP) and a leucine binding protein (LBP). The ionotropic glutamate receptors (iGluRs) have an integral ion channel and are subdivided into three major groups based on their pharmacology and structural similarities: NMDA receptors, AMPA receptors, and kainate receptors. The family of membrane bound guanylyl cyclases is further divided into three subfamilies: the ANP receptor (GC-A)/C-type natriuretic peptide receptor (GC-B), the heat-stable enterotoxin receptor (GC-C)/sensory organ specific membrane GCs such as retinal receptors (GC-E, GC-F), and olfactory receptors (GC-D and GC-G).


Pssm-ID: 380493 [Multi-domain]  Cd Length: 332  Bit Score: 53.19  E-value: 3.60e-08
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274  46 VLLPDDNmYQASLPRVLPILKVAEQQIRSKSLIPSHIDFEWLAHDTKCDASLGVIKAMDGIIKQCAQVIFGPVCDYSLAA 125
Cdd:cd06269   4 ALLPVHD-YLESGAKVLPAFELALSDVNSRPDLLPKTTLGLAIRDSECNPTQALLSACDLLAAAKVVAILGPGCSASAAP 82
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274 126 VSRITKYFNsqgTPLISVGGSTYDFEQKktdcnDEFYMLLRTG---MLSFETISELtinvMKRHNWSHSIFYYERD--GQ 200
Cdd:cd06269  83 VANLARHWD---IPVLSYGATAPGLSDK-----SRYAYFLRTVppdSKQADAMLAL----VRRLGWNKVVLIYSDDeyGE 150
                       170
                ....*....|
gi 24647274 201 RSVAGMHTCF 210
Cdd:cd06269 151 FGLEGLEELF 160
PBP1_GABAb_receptor cd06366
ligand-binding domain of GABAb receptors, which are metabotropic transmembrane receptors for ...
61-190 1.55e-05

ligand-binding domain of GABAb receptors, which are metabotropic transmembrane receptors for gamma-aminobutyric acid (GABA); Ligand-binding domain of GABAb receptors, which are metabotropic transmembrane receptors for gamma-aminobutyric acid (GABA). GABA is the major inhibitory neurotransmitter in the mammalian CNS and, like glutamate and other transmitters, acts via both ligand gated ion channels (GABAa receptors) and G-protein coupled receptors (GABAb receptor or GABAbR). GABAa receptors are members of the ionotropic receptor superfamily which includes alpha-adrenergic and glycine receptors. The GABAb receptor is a member of a receptor superfamily which includes the mGlu receptors. The GABAb receptor is coupled to G alpha-i proteins, and activation causes a decrease in calcium, an increase in potassium membrane conductance, and inhibition of cAMP formation. The response is thus inhibitory and leads to hyperpolarization and decreased neurotransmitter release, for example.


Pssm-ID: 380589 [Multi-domain]  Cd Length: 404  Bit Score: 45.31  E-value: 1.55e-05
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24647274  61 VLPILKVAEQQIRSKSLIPSHIDFEWLAHDTKCDASLGvIKAMDGIIKQCAQ--VIFGPVCDYSLAAVSRITKYFNsqgT 138
Cdd:cd06366  20 ILPAAEMALEHINNRSDILPGYNLELIWNDTQCDPGLG-LKALYDLLYTPPPkvMLLGPGCSSVTEPVAEASKYWN---L 95
                        90       100       110       120       130
                ....*....|....*....|....*....|....*....|....*....|....*..
gi 24647274 139 PLISVGGSTYDFEQKKTdcndeFYMLLRTgmlsfeTISELT-----INVMKRHNWSH 190
Cdd:cd06366  96 VQLSYAATSPALSDRKR-----YPYFFRT------VPSDTAfnparIALLKHFGWKR 141
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH